![Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials - The Lancet Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials - The Lancet](https://www.thelancet.com/cms/attachment/6d79da4c-93a3-46de-af9b-484ab1913b53/gr1.jpg)
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials - The Lancet
High-Resolution Fluorescence Spectra of Airborne Biogenic Secondary Organic Aerosols: Comparisons to Primary Biological Aerosol Particles and Implications for Single-Particle Measurements | Environmental Science & Technology
![Sustainability | Free Full-Text | Determining the Contributions in a Denim Fabric Production for Sustainable Development Goals: Life Cycle Assessment and Material Input Approaches Sustainability | Free Full-Text | Determining the Contributions in a Denim Fabric Production for Sustainable Development Goals: Life Cycle Assessment and Material Input Approaches](https://pub.mdpi-res.com/sustainability/sustainability-15-05315/article_deploy/html/images/sustainability-15-05315-g001.png?1679034943)
Sustainability | Free Full-Text | Determining the Contributions in a Denim Fabric Production for Sustainable Development Goals: Life Cycle Assessment and Material Input Approaches
![Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Oncology Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/1ed2d6f1-ced6-4ed1-a7f2-bd3bf926b68e/gr1.jpg)
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Oncology
Stereoselective Primary and Secondary Nucleation Events in Multicomponent Seeded Supramolecular Polymerization | Journal of the American Chemical Society
![2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association | Circulation 2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association | Circulation](https://www.ahajournals.org/cms/asset/e336fbdd-4a35-4bbf-89d0-092eef4fbf3f/cir.0000000000001031.fig01.jpg)